An observational study in Critical Illness and Dietary Modification, sponsored by Société des Produits Nestlé (SPN). Completed at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-09-25.
Sponsored by Société des Produits Nestlé (SPN) (part of Nestlé S.A.) · Observational
This is a retrospective study of protein and energy intake in enterally fed critically ill adult patients before and after the introduction of a very high protein enteral nutrition formula in a single center medical/surgical ICU.
1,780 studies on the registry are indexed under Critical Illness; 442 are open to participants now.
This study's enrollment of 40 is below the median of 140 across 814 observational studies indexed under Critical Illness.
Browse Critical Illness studies →Société des Produits Nestlé (SPN) is the lead sponsor of 324 studies on the registry; 16 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult medical/surgical ICU patients that received enteral nutrition with or without a very high protein enteral nutrition formula.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
20 enterally fed critically ill adult patients prior to the introduction of a very high protein enteral nutrition formula \[2015\].
20 enterally fed critically ill adult patients post the introduction of a very high protein enteral nutrition formula \[2016\].
Daily total protein intake
Daily total protein intake and percent prescribed protein needs met during first week of ICU admission.
Time frame: Daily up to 7 days of ICU stay
Daily caloric intake - Total Calories
Total calories aggregate from all sources
Time frame: Daily up to 7 days of ICU stay
Daily caloric intake - kcal/kg
Total volume consumed and weight will be used to measure kcal/kg
Time frame: Daily up to 7 days of ICU stay
Daily caloric intake from enteral nutrition
Daily caloric intake from enteral nutrition, and medications (i.e. Propofol)
Time frame: Daily up to 7 days of ICU stay
Percentage of prescribed calorie needs met
Percentage of prescribed calorie needs met
Time frame: Daily up to 7 days of ICU stay
Feeding interruptions
Feeding interruptions; and reason for interruption, if recorded in electronic medical record/nursing flow sheets
Time frame: Daily up to 7 days of ICU stay
Use of inotropes/vasopressors (highest daily dose prescribed)
Use of inotropes/vasopressors will be documented as a Yes/No.
Time frame: Daily up to 7 days of ICU stay
Feeding tolerance
Feeding tolerance as recorded by clinicians in electronic medical record/nursing flow sheets \[gastrointestinal side effects observed and documented: vomiting, elevated Gastric Residual Volumes (\>200 mL), aspiration, pneumonia, diarrhea (Bristol stool chart definition and ≥ 3 liquid stools/day)\]
Time frame: Daily up to 7 days of ICU stay
Plan to share: No
No publications or documents are linked to this record.
Ran from Oct 2017 to primary completion in Feb 2018, 4 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Société des Produits Nestlé (SPN) →